Full Text View
Tabular View
No Study Results Posted
Related Studies
Drug Interaction Study of SAR302503 in Patients With Solid Tumor
This study has been completed.
Study NCT01585623   Information provided by Sanofi

First Received on April 13, 2012.   Last Updated on March 21, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumor
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
SAR302503
omeprazol
metoprolol
midazolam
Additional drug interventions recognized in this trial
Metoprolol succinate
More general drug interventions related to this trial
Adjuvants, Anesthesia
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Anesthetics
Anesthetics, General
Anesthetics, Intravenous
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Antihypertensive Agents
Autonomic Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Modulators
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sympatholytics
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services